Across Asia, government health and safety authorities have tightened regulations on medical devices this year, as markets continue to experience rapid change, and as the devices themselves gain sophistication and complexity at a blistering pace.
Part II reviews some lessons learned as we try to predict the trajectory and defenses to COVID-19 test cases.
Part one of this series looks at the claims brought against manufacturers of diagnostic test kits.
Companies can improve their chances for a successful transition by leveraging their knowledge of their medical devices and understanding what each device’s categorization under the MDR means to its testing strategy.
Investments in new processes and systems must satisfy the needs of the authorities and ensure patient safety and public confidence. Getting it right is likely to be expensive. but regulatory compliance shouldn’t be viewed purely as a cost center.
Having the ability to assess vital signs in real time could be the future of monitoring the health of travelers to help prevent outbreaks.
The pace of innovation in the ICU is orders of magnitude slower than that of the cath lab and OR, and the COVID-19 crisis has pushed, tested, and exposed ICUs for lacking state-of-the-art technology and resources.
In a Q&A with Zipnosis, Catherine Murphy explains the uptick in telehealth visits and how it is changing the continuum of care.
Augmented reality and extended reality will play a front-and-center role in patient care.
The continued threat and spread of COVID-19 across the globe has led to seismic uncertainty for every industry.
